Principle Wealth Partners LLC Trims Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Principle Wealth Partners LLC reduced its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 0.5% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 7,522 shares of the healthcare conglomerate’s stock after selling 40 shares during the period. Principle Wealth Partners LLC’s holdings in UnitedHealth Group were worth $3,805,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of UNH. International Private Wealth Advisors LLC boosted its position in shares of UnitedHealth Group by 13.9% during the fourth quarter. International Private Wealth Advisors LLC now owns 722 shares of the healthcare conglomerate’s stock valued at $365,000 after purchasing an additional 88 shares in the last quarter. Panoramic Capital Partners LLC bought a new position in shares of UnitedHealth Group in the 4th quarter worth about $684,000. Arlington Trust Co LLC boosted its stake in UnitedHealth Group by 27.6% during the fourth quarter. Arlington Trust Co LLC now owns 2,323 shares of the healthcare conglomerate’s stock worth $1,175,000 after acquiring an additional 502 shares in the last quarter. Equitable Trust Co. lifted its holdings in shares of UnitedHealth Group by 6.4% during the fourth quarter. Equitable Trust Co. now owns 11,590 shares of the healthcare conglomerate’s stock valued at $5,863,000 after purchasing an additional 699 shares during the last quarter. Finally, Soltis Investment Advisors LLC grew its stake in shares of UnitedHealth Group by 17.2% in the 4th quarter. Soltis Investment Advisors LLC now owns 21,444 shares of the healthcare conglomerate’s stock worth $10,848,000 after buying an additional 3,148 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Trading Up 1.2 %

UNH stock opened at $533.17 on Tuesday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The firm has a fifty day moving average price of $529.18 and a 200 day moving average price of $564.40. The firm has a market cap of $490.66 billion, a PE ratio of 34.40, a price-to-earnings-growth ratio of 1.45 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same period in the previous year, the firm earned $5.83 earnings per share. UnitedHealth Group’s quarterly revenue was up 6.8% compared to the same quarter last year. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

Insider Transactions at UnitedHealth Group

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the stock in a transaction on Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.33% of the company’s stock.

Wall Street Analyst Weigh In

UNH has been the topic of a number of recent research reports. TD Cowen increased their target price on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Wells Fargo & Company reduced their target price on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Bank of America reduced their price target on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Finally, Deutsche Bank Aktiengesellschaft lifted their target price on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research report on Tuesday, December 3rd. One analyst has rated the stock with a hold rating, twenty have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.